Indirect Discrimination and Inequality
Indirect Discrimination and Inequality Author:Shu IshidaJournal:Handbook of Equality of Opportunity June 22, 2024 https://doi.org/10.1007/978-3-031-55897-9_81
Indirect Discrimination and Inequality Author:Shu IshidaJournal:Handbook of Equality of Opportunity June 22, 2024 https://doi.org/10.1007/978-3-031-55897-9_81
入門 科学技術と社会 Author:Shu Ishida担当範囲:第20章 脳神経科学 April 27, 2024 https://www.amazon.co.jp/dp/4779517796?linkCode=osi&th=1&psc=1
入門 科学技術と社会 Author:Chie Kabayashi担当範囲:第9章 デュアルユース April 27, 2024 https://www.amazon.co.jp/dp/4779517796?linkCode=osi&th=1&psc=1
Welfare Subjectivism, Sophistication, and Procedural Perfectionism Author:Shu IshidaJournal:The Journal of Ethics April 21, 2024 https://doi.org/10.1007/s10892-024-09477-6
April 9, 2024 Are Lab-grown Brain Tissues Ethical? There Is No No-brainer Answer Insights into ethical and legal ramifications of growing brain organoids from human fetal brain tissue. Brain organoids, though often referred to as “mini brains,” are not truly human brains. But the concerns over these lab-grown brain tissues, especially when they are developed from human fetal tissues, can be very human indeed.Researchers from the Graduate School of Humanities and Social Sciences at Hiroshima University offer valuable insights into the complexities inherent in brain organoid research, making significant contributions to the ongoing discourse surrounding this innovative biotechnology and paving the way for informed decision-making and legal and ethical stewardship in the pursuit of scientific advancement.Their paper was published on March 4 in EMBO Reports. Brain organoids are three-dimensional human brain tissues derived from stem cells, which are capable of developing into many differe
Navigating equity in global access to genome therapy expanding access to potentially transformative therapies and benefiting those in need requires global policy changes Author:Tsung-Ling Lee, Tsutomu SawaiJournal:Frontiers in Genetics April 4, 2024 https://doi.org/10.3389/fgene.2024.1381172
しないに越したことはない——超義務と亜義務の倫理学 Author:Keisuke Urano, Shu IshidaJournal:応用倫理 March 31, 2024 https://doi.org/10.14943/ouyourin.15.15
実験医学 2024年4月 Vol.42 No.6 動き始めたゲノム編集の医療応用〜免疫再生医療からダウン症治療、異種移植までin vivo/ex vivoでの多彩なアプローチ Author:Tsutomu Sawai, Masanori Kataoka, Miho Kaneko担当範囲:ヒトゲノム編集における責任ある研究開発・臨床応用に向けて March 19, 2024 https://doi.org/10.18958/7431-00001-0001387-00
The ethical and legal challenges of human foetal brain tissue-derived organoids: At the intersection of science, ethics, and regulation Author:Tsutomu Sawai, Masanori KataokaJournal:EMBO reports March 4, 2024 https://doi.org/10.1038/s44319-024-00099-5
February 29, 2024 Proposals for Cell Donation Procedures to Create Brain Organoids With advances in neuroscience and the development of new technologies, new ethical considerations have emerged. This is particularly true for human brain organoids, which are three-dimensional tissues grown from stem cells that partially replicate the characteristics of the human brain. Brain organoids have emerged as important tools for studying brain development and disease, but there are concerns about the possibility of these organoids developing consciousness. This has important implications for research ethics and the need to obtain informed consent from cell donors. To address these questions, an international team of researchers has sought to shed light on the intricate ethical landscape of brain organoid research, offering insights that will be important for researchers, ethicists, and policymakers alike. Through a comprehensive literature review and ethical analysis, they examined how the pote